https://www.gosh.nhs.uk/news/update-for-patients-and-families-on-industrial-action/
Update for patients and families on industrial action
11 Nov 2025, 4 p.m.
As you may be aware, some of our Resident Doctors will be taking part in planned industrial action from 7am on Friday 14 November to 7am on Wednesday 19 November.
Please be reassured that providing safe care for our patients and families remains our priority, and we are working hard to continue to best support all our patients and families. Please do still come to the hospital as planned unless you’re advised otherwise by your clinical team.
Who can I speak to if I have further questions?
This is a difficult situation, and we know that this may cause you added worry or concern. Please speak to your clinical team or contact our Patient Advice and Liaison Service (PALS)if you have any further questions:
Email: pals@gosh.nhs.uk
Telephone: 020 7829 7862
Finally, we want to thank our patients, families and carers for their understanding at this difficult time.
NIHR launches £13.7m investment into brain tumour research
The National Institute for Health and Care Research (NIHR) has announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.
New consortium aims to help improve care for arthritis patients
A new UK-led research group, including Great Ormond Street Hospital and University College London, aims to improve the lives of children, young people and adults with arthritis by defining for the first time what being in ‘remission’ from arthritis truly
Great Ormond Street Hospital joins the Circular Economy Healthcare Alliance (CEHA)
By joining CEHA, Great Ormond Street Hospital reaffirms its commitment to ‘do no harm’—not only to our patients, but to the environment and future generations.
‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-Cell leukaemia
A groundbreaking new treatment using gene-edited immune cells, developed at GOSH and UCL has shown promising results in helping children and adults fight a rare and aggressive cancer